Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
255
-
Total 13F shares, excl. options
-
50.3M
-
Shares change
-
+2.16M
-
Total reported value, excl. options
-
$3.01B
-
Value change
-
+$131M
-
Put/Call ratio
-
0.88
-
Number of buys
-
128
-
Number of sells
-
-104
-
Price
-
$59.84
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q4 2020
289 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q4 2020.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 255 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.3M shares
.
Largest 10 shareholders include BlackRock Inc. (7.1M shares), VANGUARD GROUP INC (4.37M shares), MACQUARIE GROUP LTD (2.75M shares), RENAISSANCE TECHNOLOGIES LLC (2.63M shares), Spyglass Capital Management LLC (1.97M shares), BAILLIE GIFFORD & CO (1.96M shares), STATE STREET CORP (1.42M shares), PAULSON & CO. INC. (1.41M shares), WELLS FARGO & COMPANY/MN (1.4M shares), and LOOMIS SAYLES & CO L P (1.13M shares).
This table shows the top 255 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.